TPCW
PFE icon

TD Private Client Wealth’s Pfizer PFE Stock Holding History

TD Private Client Wealth’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.23M Buy
217,302
+11,206
+5% +$293K 0.1% 138
2026
Q1 		$5.79M Buy
206,096
+21,821
+12% +$581K 0.12% 118
2025
Q4 		$4.59M Sell
184,275
-49,405
-21% -$1.25M 0.1% 138
2025
Q3 		$5.95M Buy
233,680
+80,571
+53% +$1.99M 0.13% 107
2025
Q2 		$3.71M Buy
153,109
+25,456
+20% +$594K 0.09% 159
2025
Q1 		$3.23M Buy
127,653
+29,754
+30% +$779K 0.09% 158
2024
Q4 		$2.6M Sell
97,899
-26,813
-21% -$727K 0.07% 187
2024
Q3 		$3.61M Buy
124,712
+3,307
+3% +$96.5K 0.1% 148
2024
Q2 		$3.4M Buy
121,405
+8,060
+7% +$222K 0.11% 144
2024
Q1 		$3.15M Sell
113,345
-1,438
-1% -$39.9K 0.1% 153
2023
Q4 		$3.31M Sell
114,783
-26,365
-19% -$797K 0.12% 144
2023
Q3 		$4.68M Sell
141,148
-16,358
-10% -$578K 0.2% 99
2023
Q2 		$5.78M Buy
157,506
+7,638
+5% +$297K 0.25% 82
2023
Q1 		$6.11M Buy
149,868
+18,525
+14% +$800K 0.27% 82
2022
Q4 		$6.73M Buy
131,343
+13,675
+12% +$656K 0.32% 64
2022
Q3 		$5.15M Buy
117,668
+3,661
+3% +$178K 0.26% 84
2022
Q2 		$5.98M Sell
114,007
-12,426
-10% -$633K 0.29% 72
2022
Q1 		$6.55M Buy
126,433
+13,220
+12% +$686K 0.28% 77
2021
Q4 		$6.69M Sell
113,213
-112,714
-50% -$5.58M 0.28% 74
2021
Q3 		$9.72M Sell
225,927
-83,047
-27% -$3.68M 0.42% 48
2021
Q2 		$12.1M Buy
308,974
+10,660
+4% +$415K 0.52% 38
2021
Q1 		$10.8M Sell
298,314
-16,503
-5% -$586K 0.5% 38
2020
Q4 		$11.6M Sell
314,817
-60,213
-16% -$2.21M 0.59% 31
2020
Q3 		$13.1M Sell
375,030
-21,617
-5% -$758K 0.73% 25
2020
Q2 		$12.3M Sell
396,647
-76,618
-16% -$2.6M 0.72% 26
2020
Q1 		$14.7M Buy
473,265
+24,136
+5% +$822K 1.05% 13
2019
Q4 		$16.7M Buy
+449,129
New +$16M 1% 17

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

TD Private Client Wealth's PFE Position: Q2 2026 in Review

TD Private Client Wealth increased its Pfizer (PFE) stake by 5.4% in Q2 2026, buying an estimated $293K and bringing the position to 217,302 shares worth $5.23M. The position accounts for 0.1% of the portfolio, ranked #138.

TD Private Client Wealth first reported a position in PFE in Q4 2019 and has held it in 27 quarters since. The position peaked at $16.7M in Q4 2019. 2,826 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • TD Private Client Wealth held 217,302 shares of Pfizer worth $5.23M as of Q2 2026.
  • TD Private Client Wealth bought 11,206 Pfizer shares in Q2 2026, an estimated $293K.
  • Pfizer made up 0.1% of TD Private Client Wealth's portfolio in Q2 2026, its #138 holding.
  • TD Private Client Wealth first reported a position in Pfizer in Q4 2019 and has held it in 27 quarters since.
  • TD Private Client Wealth's Pfizer position peaked at $16.7M in Q4 2019.
  • 2,826 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on TD Private Client Wealth's 13F filing for Q2 2026, filed 4 Aug 2026.